• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4602587)   Today's Articles (2336)   Subscriber (49368)
For: Pugliese A, Tobyn M, Hawarden LE, Abraham A, Blanc F. New Development in Understanding Drug-Polymer Interactions in Pharmaceutical Amorphous Solid Dispersions from Solid-State Nuclear Magnetic Resonance. Mol Pharm 2022;19:3685-3699. [PMID: 36037249 DOI: 10.1021/acs.molpharmaceut.2c00479] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Number Cited by Other Article(s)
1
Mahmood WK, Dakhal GY, Younus D, Issa AA, El-Sayed DS. Comparative properties of ZnO modified Au/Fe nanocomposite: electronic, dynamic, and locator annealing investigation. J Mol Model 2024;30:165. [PMID: 38735975 DOI: 10.1007/s00894-024-05956-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2024] [Accepted: 04/27/2024] [Indexed: 05/14/2024]
2
Huzjak T, Jakasanovski O, Berginc K, Puž V, Zajc-Kreft K, Jeraj Ž, Janković B. Overcoming drug impurity challenges in amorphous solid dispersion with rational development of biorelevant dissolution-permeation method. Eur J Pharm Sci 2024;192:106655. [PMID: 38016626 DOI: 10.1016/j.ejps.2023.106655] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2023] [Revised: 10/26/2023] [Accepted: 11/25/2023] [Indexed: 11/30/2023]
3
Ueda H, Hirakawa Y, Miyano T, Nakayama Y, Hatanaka Y, Uchiyama H, Tozuka Y, Kadota K. Improvement in Inhalation Properties of Theophylline and Levofloxacin by Co-Amorphization and Enhancement in Its Stability by Addition of Amino Acid as a Third Component. Mol Pharm 2023;20:6368-6379. [PMID: 37942959 DOI: 10.1021/acs.molpharmaceut.3c00756] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2023]
4
Kojima T, Takeda J, Song Y, Yamamoto K, Ikeda Y. Polymer-inducing chemical degradation of amorphous solid dispersions driven by drug-polymer interactions for physical stabilization. Int J Pharm 2023;647:123504. [PMID: 37832704 DOI: 10.1016/j.ijpharm.2023.123504] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2023] [Revised: 09/30/2023] [Accepted: 10/09/2023] [Indexed: 10/15/2023]
5
Chen Z, Nie H, Benmore CJ, Smith PA, Du Y, Byrn S, Templeton AC, Su Y. Probing Molecular Packing of Amorphous Pharmaceutical Solids Using X-ray Atomic Pair Distribution Function and Solid-State NMR. Mol Pharm 2023;20:5763-5777. [PMID: 37800667 DOI: 10.1021/acs.molpharmaceut.3c00628] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/07/2023]
6
Choi MJ, Woo MR, Baek K, Park JH, Joung S, Choi YS, Choi HG, Jin SG. Enhanced Oral Bioavailability of Rivaroxaban-Loaded Microspheres by Optimizing the Polymer and Surfactant Based on Molecular Interaction Mechanisms. Mol Pharm 2023;20:4153-4164. [PMID: 37433746 DOI: 10.1021/acs.molpharmaceut.3c00281] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/13/2023]
7
Electronic band structure and density of state modulation of amphetamine and ABW type-zeolite adsorption system: DFT-CASTEP analysis. J Mol Model 2023;29:96. [PMID: 36912996 DOI: 10.1007/s00894-023-05501-y] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2022] [Accepted: 03/06/2023] [Indexed: 03/14/2023]
8
Moroni AB, Mayoral EP, Lionello DF, Vega DR, Kaufman TS, Calvo NL. Solid-state properties of Nifurtimox. Preparation, analytical characterization, and stability of an amorphous phase. Eur J Pharm Biopharm 2023;184:25-35. [PMID: 36681284 DOI: 10.1016/j.ejpb.2023.01.008] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2022] [Revised: 01/13/2023] [Accepted: 01/13/2023] [Indexed: 01/19/2023]
9
Zhao P, Han W, Shu Y, Li M, Sun Y, Sui X, Liu B, Tian B, Liu Y, Fu Q. Liquid-liquid phase separation drug aggregate: Merit for oral delivery of amorphous solid dispersions. J Control Release 2023;353:42-50. [PMID: 36414193 DOI: 10.1016/j.jconrel.2022.11.033] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2022] [Revised: 11/15/2022] [Accepted: 11/16/2022] [Indexed: 11/23/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA